NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.5400
+0.0450 (9.09%)
Aug 28, 2026, 3:59 PM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 52.05 million as of August 28, 2026. Its market cap has decreased by -22.98% in one year.
Market Cap
52.05M
Enterprise Value
50.04M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
ChartMarket Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 52.05M, an increase of 55.46%. That is a compound annual growth rate of 11.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 52.05M | -13.03% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 49.12M |
| ME Therapeutics Holdings | 45.58M |
| BriaCell Therapeutics | 45.15M |
| Sona Nanotech | 44.21M |
| Microbix Biosystems | 43.83M |
| Medicenna Therapeutics | 42.46M |
| Sernova Biotherapeutics | 41.54M |
| Telescope Innovations | 41.22M |